Literature DB >> 28119059

Chronic fluoxetine treatment directs energy metabolism towards the citric acid cycle and oxidative phosphorylation in rat hippocampal nonsynaptic mitochondria.

Dragana Filipović1, Victor Costina2, Ivana Perić3, Andrijana Stanisavljević3, Peter Findeisen2.   

Abstract

Fluoxetine (Flx) is the principal treatment for depression; however, the precise mechanisms of its actions remain elusive. Our aim was to identify protein expression changes within rat hippocampus regulated by chronic Flx treatment versus vehicle-controls using proteomics. Fluoxetine-hydrohloride (15mg/kg) was administered daily to adult male Wistar rats for 3weeks, and cytosolic and nonsynaptic mitochondrial hippocampal proteomes were analyzed. All differentially expressed proteins were functionally annotated according to biological process and molecular function using Uniprot and Blast2GO. Our comparative study revealed that in cytosolic and nonsynaptic mitochondrial fractions, 60 and 3 proteins respectively, were down-regulated, and 23 and 60 proteins, respectively, were up-regulated. Proteins differentially regulated in cytosolic and nonsynaptic mitochondrial fractions were primarily related to cellular and metabolic processes. Of the identified proteins, the expressions of calretinin and parvalbumine were confirmed. The predominant molecular functions of differentially expressed proteins in both cell hippocampal fractions were binding and catalytic activity. Most differentially expressed proteins in nonsynaptic mitochondria were catalytic enzymes involved in the pyruvate metabolism, citric acid cycle, oxidative phosphorylation, ATP synthesis, ATP transduction and glutamate metabolism. Results indicate that chronic Flx treatment may influence proteins involved in calcium signaling, cytoskeletal structure, chaperone system and stimulates energy metabolism via the upregulation of GAPDH expression in cytoplasm, as well as directing energy metabolism toward the citric acid cycle and oxidative phosphorylation in nonsynaptic mitochondria. This approach provides new insight into the chronic effects of Flx treatment on protein expression in a key brain region associated with stress response and memory. Copyright Â
© 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fluoxetine; Mass spectrometry-based proteomics; Nonsynaptic mitochondria; Rat hippocampus; Signaling networks

Mesh:

Substances:

Year:  2017        PMID: 28119059     DOI: 10.1016/j.brainres.2017.01.025

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

Review 1.  Molecular Mechanisms Associated with Antidepressant Treatment on Major Depression.

Authors:  Lívia Ramos-da-Silva; Pamela T Carlson; Licia C Silva-Costa; Daniel Martins-de-Souza; Valéria de Almeida
Journal:  Complex Psychiatry       Date:  2021-07-09

2.  Integrative multi-omics landscape of fluoxetine action across 27 brain regions reveals global increase in energy metabolism and region-specific chromatin remodelling.

Authors:  Vibhor Kumar; Jonathan Aow; Naghmeh Rastegar; Michelle Gek Liang Lim; Nicholas O'Toole; Nirmala Arul Rayan; Edita Aliwarga; Danusa Mar Arcego; Hui Ting Grace Yeo; Jen Yi Wong; May Yin Lee; Florian Schmidt; Hajira Shreen Haja; Wai Leong Tam; Tie-Yuan Zhang; Josie Diorio; Christoph Anacker; Rene Hen; Carine Parent; Michael J Meaney; Shyam Prabhakar
Journal:  Mol Psychiatry       Date:  2022-09-02       Impact factor: 13.437

3.  Distinct proteomic profiles in prefrontal subareas of elderly major depressive disorder and bipolar disorder patients.

Authors:  Yang-Jian Qi; Yun-Rong Lu; Li-Gen Shi; Jeroen A A Demmers; Karel Bezstarosti; Erikjan Rijkers; Rawien Balesar; Dick Swaab; Ai-Min Bao
Journal:  Transl Psychiatry       Date:  2022-07-11       Impact factor: 7.989

Review 4.  Psychiatric drugs impact mitochondrial function in brain and other tissues.

Authors:  Shawna T Chan; Michael J McCarthy; Marquis P Vawter
Journal:  Schizophr Res       Date:  2019-11-16       Impact factor: 4.939

Review 5.  Prescription drugs and mitochondrial metabolism.

Authors:  Cameron A Schmidt
Journal:  Biosci Rep       Date:  2022-04-29       Impact factor: 3.976

Review 6.  Mitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression.

Authors:  Josh Allen; Raquel Romay-Tallon; Kyle J Brymer; Hector J Caruncho; Lisa E Kalynchuk
Journal:  Front Neurosci       Date:  2018-06-06       Impact factor: 4.677

7.  Metabolite-related antidepressant action of diterpene ginkgolides in the prefrontal cortex.

Authors:  Qingchuan Hu; Peng Shen; Shunjie Bai; Meixue Dong; Zihong Liang; Zhi Chen; Wei Wang; Haiyang Wang; Siwen Gui; Pengfei Li; Peng Xie
Journal:  Neuropsychiatr Dis Treat       Date:  2018-04-13       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.